Abbas Dehghan MD PhD FESCis a medical doctor and an epidemiologist. He studied Epidemiology at Netherlands Institute for Health Sciences (NIHES) and worked with the Rotterdam Study at the department of epidemiology, Erasmus Medical Center, the Netherlands for more than 10 years. In 2016, he joined the Department of Epidemiology and Biostatistics at Imperial College London as a reader in cardiometabolic disorders.
Dr Dehghan is a member of the steering committee of the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium and has led or been involved in many genome-wide association (GWAS) studies. He has been co-PI of COMBI-BIO, an FP7 EU funded project on the metabolomics of atherosclerosis.
Dr Dehghan is working on the genetics of omics, in particular metabolomics, and applying Mendelian Randomisation approach to investigate causal determinants of complex traits and diseases including cardiometabolic disorders, dementia and cancers.
Since January 2020, Dr Dehghan is the director of postgraduate research at the school of public health.
et al., 2022, The genomics of heart failure: design and rationale of the HERMES consortium, Esc Heart Failure, Vol:8, ISSN:2055-5822, Pages:5531-5541
et al., 2022, Associations of genetically predicted fatty acid levels across the phenome: A mendelian randomisation study., Plos Med, Vol:19
et al., 2022, Associations of Genetically Predicted Vitamin B12 Status across the Phenome, Nutrients, ISSN:2072-6643
et al., 2022, Inflammatory diseases, inflammatory biomarkers, and Alzheimer disease: an observational analysis and mendelian randomization, Neurology, ISSN:0028-3878
et al., 2022, Pleiotropic genetic architecture and novel loci for C-reactive protein levels, Nature Communications, ISSN:2041-1723